Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies
- 1 March 2007
- journal article
- Published by Springer Science and Business Media LLC in AAPS PharmSciTech
- Vol. 8 (1), E1-E12
- https://doi.org/10.1208/pt0801001
Abstract
The purpose of this study was to formulate topically effective controlled release ophthalmic acetazolamide liposomal formulations. Reverse-phase evaporation and lipid film hydration methods were used for the preparation of reversephase evaporation (REVs) and multilamellar (MLVs) acetazolamide liposomes consisting of egg phosphatidylcholine (PC) and cholesterol (CH) in the molar ratios of (7∶2), (7∶4), (7∶6), and (7∶7) with or without stearylamine (SA) or dicetyl phosphate (DP) as positive and negative charge inducers, respectively. The prepared liposomes were evaluated for their entrapment efficiency and in vitro release. Multilamellar liposomes entrapped greater amounts of drug than REVs liposomes. Drug loading was increased by increasing CH content as well as by inclusion of SA. Drug release rate showed an order of negatively charged > neutral > positively charged liposomes, which is the reverse of the data of drug loading efficiency. Physical stability study indicated that approximately 89%, 77%, and 69% of acetazolamide was retained in positive, negative, and neutral MLVs liposomal formulations up to a period of 3 months at 4°C. The intraocular pressure (IOP)-lowering activity of selected acetazolamide liposomal formulations was determined and compared with that of plain liposomes and acetazolamide solution. Multilamellar acetazolamide liposomes revealed more prolonged effect than REVs liposomes. The positively charged and neutral liposomes exhibited greater lowering in IOP and a more prolonged effect than the negatively charged ones. The positive multilamellar liposomes composed of PC:CH:SA (7:4:1) molar ratio showed the maximal response, which reached a value of −7.8±1.04 mmHg after 3 hours of topical administration.Keywords
This publication has 33 references indexed in Scilit:
- Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamideInternational Journal of Pharmaceutics, 2005
- Vesicular systems in ocular drug delivery: an overviewInternational Journal of Pharmaceutics, 2003
- Acetazolamide: future perspective in topical glaucoma therapeuticsInternational Journal of Pharmaceutics, 2002
- Ocular Preparations: The Formulation ApproachDrug Development and Industrial Pharmacy, 2002
- Formulation and evaluation of ophthalmic preparations of acetazolamideInternational Journal of Pharmaceutics, 2000
- Preparation and evaluation of acetazolamide liposomes as an ocular delivery systemInternational Journal of Pharmaceutics, 1997
- Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbitsJournal of Pharmacy and Pharmacology, 1994
- N-Substituted sulfonamide carbonic anhydrase inhibitors with topical effects on intraocular pressureJournal of Medicinal Chemistry, 1986
- The in vitro release of steroids from liposomesInternational Journal of Pharmaceutics, 1983
- Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.Proceedings of the National Academy of Sciences of the United States of America, 1978